SELLAS Life Sciences Group, Inc. (SLS): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2023-12-31
$7.60M2019-12-31: $02020-12-31: $1.90M2021-12-31: $7.60M2022-12-31: $1.00M2023-12-31: $0$0
2019-12-31 Revenue (USD) 2023-12-31
Period endedRevenueChange YoYSource filing
2023-12-31$0-100.0%2024-03-28, From 2023-01-01
2022-12-31$1.00M-86.8%2024-03-28, From 2022-01-01
2021-12-31$7.60M+300.0%2023-03-16, From 2021-01-01
2020-12-31$1.90Mn/a2022-03-31, From 2020-01-01
2019-12-31$0n/a2021-03-23, From 2019-01-01